Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet (London, England). 2008;371:1800–9.
Evangelista I, Nuti R, Picchioni T, Dotta F, Palazzuoli A. Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy. Int J Mol Sci. 2019;20:3264.
Gaurav SG, Athithan L, Gerry PM. Diabetic cardiomyopathy: prevalence, determinants and potential treatments. Ther Adv Endocrinol Metab. 2019;10:2042018819834869.
Boodhwani M, Neel RS, Mieno S, Xu SH, Feng J, Ramlawi B, et al. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007;116:I31–7.
Zheng L, Shen CL, Li JM, Ma YL, Yan N, Tian XQ, et al. Assessment of the preventive effect against diabetic cardiomyopathy of FGF1-loaded nanoliposomes combined with microbubble cavitation by ultrasound. Front Pharmacol. 2019;10:1535.
Sara N, Edna S, João F, Sofia V, Eugénia C, Frederico CP, et al. Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker. Cardiovasc Diabetol. 2013;12:44–44.
Sypalo A, Kravchun P, Kadykova O. The influence of mono- and multivascular lesions of coronary arteries on the course of coronary heart disease in patients with diabetes mellitus type 2. Georgian Med News. 2017;264:61–5.
Hinkel R, Howe A, Renner S, Ng J, Lee S, Klett K, et al. Diabetes mellitus-induced microvascular destabilization in the myocardium. J Am Coll Cardiol. 2017;69:131–43.
Singla D, Wang J. Fibroblast growth factor-9 activates c-Kit progenitor cells and enhances angiogenesis in the infarcted diabetic heart. Oxidative Med Cell Longev. 2016;2016:5810908.
Dai XZ, Yan XQ, Zeng J, Chen J, Wang YH, Chen J, et al. Elevating CXCR7 improves angiogenic function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 activation in diabetic limb ischemia. Circ Res. 2017;120:e7–23.
Teng X, Ji C, Zhong H, Zheng D, Ni R, Hill DJ, et al. Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis. Diabetologia. 2019;62:860–72.
Zhao YZ, Tian XQ, Zhang M, Cai L, Ru A, Shen XT, et al. Functional and pathological improvements of the hearts in diabetes model by the combined therapy of bFGF-loaded nanoparticles with ultrasound-targeted microbubble destruction. J Controll Release Off J Controll Release Soc. 2014;186:22–31.
Zhao YZ, Zhang M, Ho LW, Tian XQ, Zheng L, Yu XC, et al. Prevent diabetic cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded nanoparticles and ultrasound-targeted microbubble destruction technique. J Controll Release Off J Controll Release Soc. 2016;223:11–21.
Dietrich CF. Comments and illustrations regarding the guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS)—update 2008. Ultraschall Med. 2008;29:S188–202.
Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2020-WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 2020;41:562–85.
Thomsen HS. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur J Radiol. 2006;60:307–13.
Wang XY, Pan JY, Liu H, Zhang MJ, Liu D, Lu L, et al. AIM2 gene silencing attenuates diabetic cardiomyopathy in type 2 diabetic rat model. Life Sci. 2019;221:249–58.
Xue JT, Shi YL, Li CY, Xu XJ, Xu SX, Cao MX. Methylcellulose and polyacrylate binary hydrogels used as rectal suppository to prevent type I diabetes. Colloids Surf B Biointerfaces. 2018;172:37–42.
Zheng WC, Li D, Gao X, Zhang WQ, Barry OR. Carvedilol alleviates diabetic cardiomyopathy in diabetic rats. Exp Therap Med. 2019;17:479–87.
Huang R, Shi ZD, Chen L, Zhang YQ, Li J, An Y. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice. Eur J Pharmacol. 2017;814:151–60.
Hanawa K, Ito K, Aizawa K, Shindo T, Nishimiya K, Hasebe Y, et al. Low-intensity pulsed ultrasound induces angiogenesis and ameliorates left ventricular dysfunction in a porcine model of chronic myocardial ischemia. PLoS ONE. 2014;9:e104863.
Xue JT, Zhou NQ, Yang YP, Jing Y, Qiu Y, Liu YH, et al. Puerarin-loaded ultrasound microbubble contrast agent used as sonodynamic therapy for diabetic cardiomyopathy rats. Colloids Surf B Biointerfaces. 2020;190:110887.
Tian XQ, Ni XW, Xu HL, Zheng L, ZhuGe DL, Chen B, et al. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction. Int J Nanomed. 2017;12:7103–19.
Kawaguchi M, Techigawara M, Ishihata T, Asakura T, Saito F, Maehara K, et al. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels. 1997;12:267–74.
Todd BJ, Brian HM, Xie A, Zhao Y, Kim S, Nathan JL, et al. Augmentation of limb perfusion and reversal of tissue ischemia produced by ultrasound-mediated microbubble cavitation. Circ Cardiovasc Imaging. 2015;8:e002979.
Huang JJ, Shi YQ, Li RL, Hu A, Lu ZY, Weng L, et al. Angiogenesis effect of therapeutic ultrasound on HUVECs through activation of the PI3K-Akt-eNOS signal pathway. Am J Transl Res. 2015;7:1106–15.
Zhang M, Yu WZ, Shen XT, Xiang Q, Xu J, Yang JJ, et al. Advanced interfere treatment of diabetic cardiomyopathy rats by aFGF-loaded heparin-modified microbubbles and UTMD technique. Cardiovasc Drugs Ther. 2016;30:247–61.
Chen YP, Ba LN, Huang W, Liu Y, Pan H, Mingyao E, et al. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways. Eur J Pharmacol. 2017;796:90–100.
Xu H, Xu H, Hai GF, Qing HE, Zhang C. Protective effect of modified human acidic fibroblast growth factor against actinomycin D-induced NRK52E cells apoptotic death. Trop J Pharm Res. 2013;12:343–9.